The Concord-2 global study looked at survival rates in 67 countries
for patients diagnosed with lung, breast, colon and stomach cancers in
1995 to 1999, compared with levels in 2005 to 2009.
It acknowledged there had been improvements in rates in the UK,
where cancer survival has doubled in the last 40 years, but not enough
to catch up with levels achieved in many European countries a decade
earlier. Macmillan found that by comparison UK cancer survival rates
were “stuck in the 1990s”. One of the most stark examples was lung cancer, which only 7% of
patients survived in the 1990s in the UK. The rate improved to 10% a
decade later but this was still behind a 14% survival rate achieved in
Austria in the 1990s. By the 2000s 18% of patients diagnosed with lung
cancer in Austria survived, almost twice the rate in the UK. Five other European countries (Finland, Germany, Italy, the
Netherlands and Norway) also recorded better survival rates for lung
cancer in the 1990s than Britain in the 2000s. A similar pattern emerged for breast cancer. In the past decade the
survival rate was 81% in the UK, a level exceeded 10 years before in
Sweden, France and Italy. For colon cancer six European countries
(Finland, France, Italy, the Netherlands, Norway and Sweden) had better
survival rates in the 1990s than Britain achieved 10 years later. In the
2000s 19% of British patients diagnosed with stomach cancer survived.
Better survival rates were recorded a decade earlier in Austria,
Germany, Italy, Norway and Sweden. Macmillan said the figures showed that much better survival rates were achievable in the UK. Its chief executive, Lynda Thomas, said: “Because UK cancer survival
rates are lagging so far behind the rest of Europe, people are dying
needlessly. Frankly, this is shameful. If countries like Sweden, France,
Finland and Austria can achieve these rates, then the UK can and
should, bridge the gap.”
This site is for information on the various Chemo treatments and Stem Cell Therapies since 1992. This journey became bitter sweet in 2014, with the passing of my beautiful and dear wife. Sherry, had fought Non - Hodgkins Lymphoma(NHL) since 1990, in and out of remissions time and time again. From T-Cell therapies(1990's) to Dual Cord Blood Transplant(2014), she was in Clinical Trials over the years. This site is for informational purpose only and is not to promote the use of certain therapies.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment